Nebenwirkungen · NutropinAq
NutropinAq 10 mg/2 ml (30 IU) solution for injection. · Abschnitt 4.8 · PDF-Seite 7
HOS-091392 · Präparat HOS-084303
Table 1 contains very common (≥ 1/10), common (≥ 1/100, < 1/10); uncommon (≥ 1/1000, < 1/100); rare (≥ 1/10,000, < 1/1,000) adverse reactions which occurred in clinical trials and a post-marketing surveillance survey. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Other adverse reactions have been identified during post approval use of NutropinAq. Because these reactions are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-07-20T14:29:00Z · SHA-256 e5bd062c361eb50bec364b174f269b43c7017d76fb675397b49680f729d1cb9a · Passage 82af7ca93b63f2789d7be0b26d4b488b86d71f4003bbb8ae12bcee061853adbd · Zeichen 2377–2924 im Abschnitt